PRESIDIO MANAGEMENT GROUP VIII L L C's Net Worth

$841 Million

Estimate Recalculated Apr 16, 2024 08:50PM EST

Who is PRESIDIO MANAGEMENT GROUP VIII L L C?

PRESIDIO MANAGEMENT GROUP VIII L L C has an estimated net worth of $841 Million. This is based on reported shares across multiple companies, which include LEADIS TECHNOLOGY INC, Altus Pharmaceuticals Inc., IMPERVA INC, Guidewire Software, Inc., AtriCure, Inc., MAXLINEAR INC, and OncoMed Pharmaceuticals Inc.

SEC CIK

PRESIDIO MANAGEMENT GROUP VIII L L C's CIK is 0001225484

Past Insider Trading and Trends

2010 was PRESIDIO MANAGEMENT GROUP VIII L L C's most active year for acquiring shares with 32 total transactions. PRESIDIO MANAGEMENT GROUP VIII L L C's most active month to acquire stocks was the month of December. 2012 was PRESIDIO MANAGEMENT GROUP VIII L L C's most active year for disposing of shares, totalling 84 transactions. PRESIDIO MANAGEMENT GROUP VIII L L C's most active month to dispose stocks was the month of July. 2011 saw PRESIDIO MANAGEMENT GROUP VIII L L C paying a total of $5,505,084.00 for 6,503,364 shares, this is the most they've acquired in one year. In 2012 PRESIDIO MANAGEMENT GROUP VIII L L C cashed out on 41,621,036 shares for a total of $189,456,532.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMPERVA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,290.11%
1.97M
—
—
2.13M
Nov 15
Form 4
+1,290.11%
1.97M
—
—
2.13M
Nov 15
Form 4
∞
152.92K
$18.00
$2,752,542.00
152.92K
Nov 9
Form 4
∞
152.92K
$18.00
$2,752,542.00
152.92K
Nov 9
Form 3
—
0
—
—
0
No matching records found

Guidewire Software, Inc. (GWRE) Snapshot price: $115.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-28.68%
-2.01M
—
—
5.01M
Sep 25
Form 4
-28.68%
-2.01M
—
—
5.01M
Sep 25
Form 4
-20.06%
-25.19K
$31.27
-$787,711.21
100.37K
Sep 17 - Sep 18
Form 4
-20.06%
-25.19K
$31.27
-$787,711.21
100.37K
Sep 17 - Sep 18
Form 4
-20.06%
-1.76M
—
—
7.02M
Sep 10
Form 4
-20.06%
-1.76M
—
—
7.02M
Sep 10
Form 4
-26.56%
-3.22M
$28.25
-$91,077,491.50
8.91M
Apr 24
Form 4
-26.56%
-3.22M
$28.25
-$91,077,491.50
8.91M
Apr 24
Form 4
+4,239.70%
11.86M
—
—
12.14M
Jan 30
Form 4
+4,239.70%
11.86M
—
—
12.14M
Jan 30
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

AtriCure, Inc. (ATRC) Snapshot price: $33.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.89%
-352.58K
—
—
1.51M
Jun 13
Form 4
-18.89%
-352.58K
—
—
1.51M
Jun 13
Form 4
-15.87%
-357.62K
$9.44
-$47,578.88
1.9M
Jun 6 - Jun 7
Form 4
-15.87%
-357.62K
$9.44
-$47,578.88
1.9M
Jun 6 - Jun 7
Form 4
+0.38%
8.47K
$5.62
$14,076.53
2.25M
Aug 10
Form 4
+0.38%
8.47K
$5.62
$14,076.53
2.25M
Aug 10
Form 4
∞
2.24M
$11.16
-$3,037,952.88
2.24M
Aug 10
Form 4
∞
2.24M
$11.16
-$3,037,952.88
2.24M
Aug 10
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

MAXLINEAR INC (MXL) Snapshot price: $17.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 21
Form 4
—
0
—
—
0
Aug 21
Form 4
-100.00%
-4.88K
$4.20
-$20,484.75
0
May 30
Form 4
-100.00%
-4.88K
$4.20
-$20,484.75
0
May 30
Form 4
∞
4.88K
—
—
4.88K
May 15
Form 4
∞
4.88K
—
—
4.88K
May 15
Form 4
-100.00%
-6.96K
$8.95
-$62,339.74
0
May 27
Form 4
-100.00%
-6.96K
$8.95
-$62,339.74
0
May 27
Form 4
+5.50%
363
$8.93
-$40,279.08
6.96K
May 25 - May 26
Form 4
+5.50%
363
$8.93
-$40,279.08
6.96K
May 25 - May 26
Form 4
-36.82%
-3.85K
$11.54
-$44,399.37
6.6K
Feb 15
Form 4
-36.82%
-3.85K
$11.54
-$44,399.37
6.6K
Feb 15
Form 4
∞
10.45K
—
—
10.45K
Feb 7
Form 4
∞
10.45K
—
—
10.45K
Feb 7
Form 4
-100.00%
-4.42K
$10.54
-$46,520.86
0
Nov 29
Form 4
-100.00%
-4.42K
$10.54
-$46,520.86
0
Nov 29
Form 4/A
-33.10%
-1.45K
$10.52
-$15,281.20
2.94K
Nov 15
Form 4/A
-33.10%
-1.45K
$10.52
-$15,281.20
2.94K
Nov 15
Form 4
-33.56%
-2.22K
$10.52
-$23,347.74
4.39K
Nov 15
Form 4
-33.56%
-2.22K
$10.52
-$23,347.74
4.39K
Nov 15
Form 4
∞
6.62K
—
—
6.62K
Nov 5
Form 4
∞
6.62K
—
—
6.62K
Nov 5
Form 4
-100.00%
-5.44M
$14.00
-$7,954,730.00
0
Mar 29
Form 4
-100.00%
-5.44M
$14.00
-$7,954,730.00
0
Mar 29
Form 4
∞
5.44M
—
—
5.44M
Mar 29
Form 4
∞
5.44M
—
—
5.44M
Mar 29
Form 3
—
0
—
—
0
No matching records found

OncoMed Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found